In vivo and in vitro studies showed that LSD1 inhibition by parnate or by an inhibitor targeting LSD1-SNAI1 interaction, leads to decreased cancer motility and invasiveness while also increasing E-cadherin [158]. The gene discussed is CDH1; the disease is cancer.